Skip to main content

Table 1 Study variables and assessment time

From: Effectiveness of iconic therapy for the reduction of borderline personality disorder symptoms among suicidal youth: study protocol for a randomised controlled trial

Instrument Assessment area Time of assessment
Primary outcomes
 BSL-23a BPD symptoms severity Baseline
After treatment
At 12 months
Secondary outcomes
 C-SSRSb Suicidal ideation or behaviour Baseline
After treatment
At 12 months
 DSM-V criteriac Non-suicidal self-injury diagnosis Baseline
After treatment
At 12 months
 CSRId Economic evaluation Baseline
At 12 months
Subsidiary measures
 IGe Daily life adjustment Baseline
After treatment
At 12 months
 CEQf Credibility/expectancy questionnaire After treatment
At 12 months
 Ad hoc scalesg Perceived subjective global improvement (self-reported) After treatment
At 12 months
 Ad hoc scalesh Perceived global improvement (family/friends reported) After treatment
At 12 months
  1. Notes. BSL-23a (Borderline Symptom List- short form); C-SSRSb (Columbia Suicide History Form); DSM-V criteriac (Non-suicidal self-injure diagnosis according to the Diagnosis and Statistical Manual of Mental Disorders, DSM- V); CSRId (Client Service Receipt Inventory); IGe (maladjustment scale); CEQf (credibility/expectancy questionnaire); Ad hoc scalesg (Perceived subjective global improvement); Ad hoc scalesh (Family and friends’ perceived global improvement)